Journal of Neurodevelopmental Disorders

Papers
(The median citation count of Journal of Neurodevelopmental Disorders is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Feasibility of delivering parent-implemented NDBI interventions in low-resource regions: a pilot randomized controlled study54
Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases48
Focus on your locus with a massively parallel reporter assay45
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group43
Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC)41
Long-term follow-up of telehealth-enabled behavioral treatment for challenging behaviors in boys with fragile X syndrome37
Consistency of parent-report SLC6A1 data in Simons Searchlight with Provider-Based Publications34
Atypical connectivity in the cortico-striatal network in NF1 children and its relationship with procedural perceptual-motor learning and motor skills33
Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study33
Neural patterns elicited by lexical processing in adolescents with specific language impairment: support for the procedural deficit hypothesis?32
RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer’s disease, and normative aging31
The effect of autistic traits on response to and side-effects of pharmacological ADHD treatment in children with ADHD: results from a prospective clinical cohort27
LiCl treatment leads to long-term restoration of spine maturation and synaptogenesis in adult Tbr1 mutants25
Innovative computational approaches shed light on genetic mechanisms underlying cognitive impairment among children born extremely preterm25
Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome25
Long-term follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder: corpus callosum white matter microstructure and neurocognitive outcomes24
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)24
Calculating genetic risk for dysfunction in pleiotropic biological processes using whole exome sequencing data22
Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description21
Correction: EEG resting-state functional connectivity: evidence for an imbalance of external/internal information integration in autism19
An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities17
Development of a phenotype ontology for autism spectrum disorder by natural language processing on electronic health records16
Trajectories of imitation skills in preschoolers with autism spectrum disorders15
Auditory processing in rodent models of autism: a systematic review14
Social attention during object engagement: toward a cross-species measure of preferential social orienting13
Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers13
Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome13
Copy number variation at the 22q11.2 locus influences prevalence, severity, and psychiatric impact of sleep disturbance13
Steady-state visual evoked potentials in children with neurofibromatosis type 1: associations with behavioral rating scales and impact of psychostimulant medication12
Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period12
0.027065992355347